Alpine Global Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
RG
EC
BBA
OM
BC
O
FFM
PAMU
Alpine Global Management's NGNE Position: Q1 2020 in Review
Alpine Global Management sold out of Neurogene (NGNE) in Q1 2020, closing a stake of 689 shares — an estimated $170K sold.
Alpine Global Management first reported a position in NGNE in Q4 2019 and held it in 1 quarter. The position peaked at $170K in Q4 2019. 60 funds tracked by Wall St. Rank hold NGNE as of Q1 2020.
- Alpine Global Management reported no remaining Neurogene position as of Q1 2020 after selling out during the quarter.
- Alpine Global Management sold 689 Neurogene shares in Q1 2020, an estimated $170K.
- Alpine Global Management first reported a position in Neurogene in Q4 2019 and held it in 1 quarter.
- Alpine Global Management's Neurogene position peaked at $170K in Q4 2019.
- 60 funds tracked by Wall St. Rank held Neurogene as of Q1 2020.
Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.